期刊文献+

乳果糖对门脉高压大鼠肠粘膜屏障功能保护作用的研究 被引量:6

Study of the Protections of Lactulose on the Intestinal Tract Barrier in Rats with Portal Hypertension
暂未订购
导出
摘要 目的探讨乳果糖对肝硬化门脉高压大鼠肠粘膜屏障功能的保护作用。方法50只雄性SD大鼠皮下注射50%CCl4橄榄油溶液,制造门脉高压模型。造模后存活大鼠随机分为:(1)治疗组;(2)对照组;(3)模型组。治疗组即乳果糖组,灌服乳果糖5mL/kg,每日2次,直至大鼠排稀便(共10d);对照组仅灌服葡萄糖水。11d后处死取全血及肝、脾、肾、和肠系膜淋巴结组织匀浆后作细菌培养,测细菌易位率;采用改良的偶氮基质显色法行内毒素测定;取回肠粘膜组织行HE、Masson染色和超微病理的观察研究;采用免疫组织化学方法测定回肠末端紧密连接蛋白(occludin)表达水平。结果治疗组细菌易位发生率较对照组和模型组均明显降低(P<0.05);与模型组、对照组比较,治疗组肝功能显著改善(P<0.01);治疗组血清内毒素水平(0.20±0.08)Eu/mL亦明显低于对照组、模型组之(0.33±0.06)Eu/mL、(0.44±0.07)Eu/mL(P<0.01);紧密连接蛋白的表达,治疗组与对照组、模型组比较,亦具有显著性差异(P<0.01)。结论口服乳果糖可以改善肠道屏障功能,减少门脉高压大鼠肠道菌群易位,减轻内毒素血症,从而一定程度上改善肝功能。 Objective To investigate the effect of lactulose on the Intestinal Tract Barrier in Rats with portal hypertension.Methods Total 50 male Sprague-Dawley rats were involved in this study.Portal hypertension were induced by injection of carbon tetrachloride(CCl4) subcutaneously.The rest modle rats were randomly divided into 3 groups:(1) group of lactulose,received lactulose syrup at daily doses of 5ml/kg according to their stool;(2) contral group,received glucose;(3) Portal hypertension group) .11days later,all the rats were sacrificed.The whole blood,the tissue of liver,spleen,kidney together with mesenteric lymph nodes were collected to make germiculture and measure the bacterial translocation.Used the improved azo matrix chromogenic method to examine the plasma endotoxin.The transmembrane binding protein(occludin) levels in terminal ileum were detected by immunohistochemistry method.The ultrastructure of intestinal epithelial tight junction in the colon and small intestine and the intestinal villi were observed by electron microscope. Results The translocation of bacteria was found in Portal hypertension group and Control group.The Lactulose group showed an improved liver function.The plasma endotoxin of Lactulose group was(0.20±0.08) Eu/mL which had a significantly difference from that of control group(0.33±0.06) Eu/mL or portal hypertension group(0.44±0.07) Eu/mL(P〈0.01) ,according to the express of occludin,it had a marked decrease in model group and control group than that of lactulose group(P〈0.01) .Conclusion Oral supplementation of lactulose could successfully maintain the intestinal tract barrier function,reduce bacterial translocation and diminish the endoxemia,thus,the liver function obtained improvement to some extent.
作者 徐义军 王超
出处 《中外医疗》 2010年第12期18-20,共3页 China & Foreign Medical Treatment
关键词 乳果糖 门脉高压 大鼠 肠粘膜屏障 Lactulose Hypertension/portal vein Rat Intestinal tract barrier
  • 相关文献

参考文献13

  • 1赵海英,王惠吉,吕治,许淑珍.肝硬化患者肠道菌群的研究[J].中华消化杂志,2003,23(7):407-409. 被引量:56
  • 2宋红丽,李永新,祝英华,石龙,崔万峰,张颖,杨晓明.门脉高压性胃病与肠道菌群失调及内毒素相关性研究[J].中国实用内科杂志,2004,24(12):741-742. 被引量:7
  • 3Kiyono H,Kweon MN,Hiroi T,et al.The mucosal immune system:from specialized immune defense to inflammation and allergy[J].Acta Odontol Scand,2001,59(3):145- 153.
  • 4Pascual S,Such J,Esteban A,et al.Intestinal pemeability is increased in patents with advanced cirrhosis[J].Hepatogastroenterology,2003,50:1482-1486.
  • 5Zuckerman MJ,Menzies IS,Ho H,et al.Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes[J].Dig Dis Sci,2004,49:621-626.
  • 6Hirano J,Yosida T,Sugiyama T,et al.The effect of lactobacillus thamnosus on enterohemprrhagic Escherichia coli infection of human intestinal cells in vitro[J].Microbial Immunol,2003,47:405-409.
  • 7O'Hara AM,O'Regan P,Fanning A,et al.Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius[J].Immunology,2006,118(2):202-215.
  • 8Guarner C,Runyon BA.Small intestinal dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis[J].Hepatology,2000,31:858 - 863.
  • 9Rolando N.Howard JP,Williams R.Bacterial and fungal infection in acute liver failure[J].Semin Liver dis,1996,16(4):389-402.
  • 10李兰娟,肖党生,吴仲文,杨青,傅素珍,陈春雷.急性肝衰竭大鼠肠道菌群和内毒素的动态研究[J].中华肝脏病杂志,2004,12(3):167-169. 被引量:15

二级参考文献26

  • 1陈穗,陈桂明,严虹,潘令嘉.肝炎后肝硬化患者肠道菌群变化初步分析[J].中华消化杂志,1995,15(2):75-77. 被引量:49
  • 2吴朝栋,李鸣真,陈春莲,张明富.内毒素诱导家兔肝损害及血浆TNF-α、IL-6水平变化的研究[J].中华消化杂志,1995,15(5):256-258. 被引量:5
  • 3龚耀先.中国修定韦氏成人智力量表(WAIS-RC)手册[M].长沙:湖南地图出版社,1992.52.
  • 4王吉耀.全国肝硬化专题学术讨论会纪要[J].中华消化杂志,1991,11(5):290-290.
  • 5Shito M, Balis UJ, Tompkins RG, et al. A fulminant hepatic failuremodel in the rat: involvement of interleukin-lbeta and tumor necrosis factor-alpha. Dig Dis Sci, 2001, 46: 1700-1708.
  • 6Goris H, de Boer F, van der Waaij D. Oral administration of antibiotics and intestinal flora associated endotoxin in mice. Scand J Infect Dis, 1986, 18: 55-63.
  • 7Wang XD, Ar-Rajab A, Andersson R, et al. The influence of surgically induced acute liver failure on the intestine in the rat. Scand J Gastroenterol, 1993, 28: 31-40.
  • 8Wang X, Soltesz V, Axelson J, et al. Cholecystokinin increases small intestinal motility and reduces enteric bacterial overgrowth and translocation in rats with surgically induced acute liver failure. Digestion,1996, 57: 67-72.
  • 9Smart HI,Triger DR.Clinical features,pathophysiology and relevance of portal hypertensive gastropathy.Endoscopy,1991,23(4):224-248
  • 10Kiyono H,Kweon MN,Hiroi T,et al.The mucosal immune system: from specialized immune defense to inflammation and allergy.Acta Odontol Scand,2001,59(3):145-153

共引文献93

同被引文献56

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部